Clinical and pathological features in patients with different subtypes of IgA nephropathy
BAO Hao,LI Leishi,LIU Zhihong,SUN Hua,ZHANG Xin,CHEN Huiping,ZENG Caihong,ZHENG Chunxia
DOI: https://doi.org/10.3969/j.issn.1006-298X.2006.05.003
2006-01-01
Abstract:Objective:To investigate the clinicopathological features in seven subtypes of IgA nephropathy(IgAN). Methodology:Based on the clinicopathological criteria, 759 cases of IgAN were divided into 7 subtypes. They were isolated microscopic hematuria (I-H,22), asymptomatic abnormal urinalysis (U-ab,336), recurrent gross hematuria (R-GH, 104), crescentic IgAN (Cres., 57), mass proteinuria (MP, 86), hypertension (HT, 149) and end-stage renal disease(ESRD, 5 cases). The retrospective analysis was made on the clinical and pathological data of different subtypes of IgAN. Results:In I-H, there was only microscopic hematuria (110±100)×10~4/ml, without hypertension, anemia and renal insufficiency. The incidence of chronic histological lesions was lower. In U-ab, there were both microscopic Hematuria (98±195)×10~4/ml and proteinuria (0.80±0.57)g/24h. 5.8 of patients were chronic renal insufficiency, and 23 were various degrees of renal interstitial fibrosis. In R-GH patients, the incidence of tonsillitis was 15.4, which significantly higher than that in other patterns (P<0.05). The count of urine red blood cells during the interval stage of gross hematuria were (214±336)×10~4/ml. In Cres. cases, urine red blood cells count (405±485)×10~4/ml ranked the highest, 21.1 of cases with mass proteinuria, 17.5 with increasing serum creatinine, and 31.5 with anemia. The incidence of cellular crescents and segmental necrosis was 50.9, which was more than that in any other patterns. In MP subtype, the mean of urinary protein excretion was (3.93±2.68)g/24h, associated with hypoalbuminaemia (29.1±6.8)g/L and hyperlipidaemia (6.99±2.67)mmol/L. Furthermore, the urine C3 and NAG was also increased significantly. In HT patients, the incidence of low molecular weight proteinuria reached 10.8, with hypotonic urine. The rate of renal insufficiency was high to 54.4, and the proportion of global sclerosis was (24.3±23.2). The ESRD subtype was a terminal condition of various subtypes of development, who needed replacement therapy. Conclusion:IgAN is a clinical syndrome with similar immunopathological features as well as different pathophysiological mechanisms. The different treatment in different subtypes of IgAN will improve the effect of treatment, and deepen the understanding of the nature of IgAN.